Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia
Ye He(Beijing University of Posts and Telecommunications), Liguang Lou(Shanghai Institute of Materia Medica), Fu Li(Chinese Academy of Sciences), Yun Li, Chengying Xie(CNH Industrial (Czechia)), Haoyu Fu(Southwest Forestry University), Xubin Bao, Yongping Xu(Second Hospital of Shandong University), Liping Sun(Yangzhou University)
Cited by 15
Related Papers
YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity <i>in vitro</i> and <i>in vivo</i>
|Cancer Science|2011|519
Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor‐2 inhibitor
|Cancer Science|2018|368
ZmLEA3, a Multifunctional Group 3 LEA Protein from Maize (Zea mays L.), is Involved in Biotic and Abiotic Stresses
|Plant and Cell Physiology|2013|216